Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TABLET
ISRCTN15948785Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Nov 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in recurrent miscarriage (RPL), female infertility and autoimmune thyroid disease (AITD) comparing Levothyroxine with Placebo (2 arms). Primary endpoint: Live birth at or beyond 34 weeks. Started Nov 2011; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
recurrent miscarriage (RPL)female infertilityautoimmune thyroid disease (AITD)
Beyond the preview
Go deeper on ISRCTN15948785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15948785.